O'Sullivan PLLC strongly supports innovative new efforts by nonprofit organizations and private companies to develop strategies whereby the world's most needy might benefit from advances in technology. Such strategies include Advance Purchase Commitments and Public-Private Partnerships generally. To this end, the firm supports the work of the following non-profit organizations:

CONRAD

CONRAD is dedicated to improving reproductive health, particularly in developing countries where the need is greatest, by supporting the development of better, safer, and more acceptable methods to prevent pregnancy and sexually transmitted infections (STIs), including HIV/AIDS. Private foundations provide additional support to two subprograms of CONRAD, the Consortium for Industrial Collaboration for Contraceptive Research (CICCR) and the Global Microbicide Project (GMP).

   

Global Alliance for Vaccines and Immunization (GAVI)

The Global Alliance for Vaccines and Immunization (GAVI) is an innovative public-private partnership formed to harness the strengths and experience of multiple partners in immunization. It is an historic alliance between the private and public sectors committed to the mission of saving children's lives and protecting people's health through the widespread use of vaccines.

Bio Ventures for Global Health (BVGH)

Spun out of the Biotechnology Industry Organization (BIO) with support from the Bill & Melinda Gates and Rockefeller Foundations, BVGH seeks to radically change the incentives for innovators to invest their own resources into global health product development.

PATH

PATH is an international, nonprofit organization that creates sustainable, culturally relevant solutions that enable communities worldwide to break longstanding cycles of poor health. By collaborating with diverse public- and private-sector partners, PATH helps provide appropriate health technologies and vital strategies that change the way people think and act.

TB Alliance

The TB Alliance is a public-private partnership accelerating the discovery and development of affordable, new TB treatments that will substantially improve the control of tuberculosis, which now infects one in three people worldwide and is a leading killer of AIDS patients.

Medicines for Malaria Venture

Medicines for Malaria Venture is a nonprofit organization created to discover, develop and deliver new affordable antimalarial drugs through effective public-private partnerships.

AgBioWorld

O'Sullivan PLLC strongly supports the development of agricultural biotechnology for the developing world. Please visit The AgBioWorld Foundation's website at www.AgBioWorld.org for a comprehensive treatment of the subject along with the latest developments.